St Goar F G, Stone G W
Stanford University Medical Center, California.
Cardiol Clin. 1994 Nov;12(4):559-71.
The management of acute myocardial infarction has evolved greatly with the development of interventional cardiology and thrombolytic therapy. Interventional strategies in the setting of thrombolytic therapy include immediate, delayed, and elective PTCA. Randomized trials suggest no benefit to these approaches; however, primary PTCA without adjunctive lytics when compared to lytic therapy alone may improve both survival and costs. Newer catheter-based technology may also enhance outcomes in patients with acute myocardial infarction.
随着介入心脏病学和溶栓治疗的发展,急性心肌梗死的治疗方法有了很大的演变。溶栓治疗背景下的介入策略包括即刻、延迟和择期经皮冠状动脉腔内血管成形术(PTCA)。随机试验表明这些方法并无益处;然而,与单纯溶栓治疗相比,不使用辅助溶栓药物的直接PTCA可能会改善生存率并降低成本。更新的基于导管的技术也可能改善急性心肌梗死患者的治疗效果。